Business Description
Sinco Pharmaceutical Holdings Ltd
ISIN : KYG8154Y1052
Compare
Compare
Traded in other countries / regions
06833.Hong Kong IPO Date
2016-03-10Description
Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.84 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | 2.16 | |||||
| Interest Coverage | 13.83 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.88 | |||||
| Beneish M-Score | -3.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.6 | |||||
| 3-Year EBITDA Growth Rate | -14.3 | |||||
| 3-Year EPS without NRI Growth Rate | -33.9 | |||||
| 3-Year FCF Growth Rate | 36 | |||||
| 3-Year Book Growth Rate | 42.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.81 | |||||
| 9-Day RSI | 51.36 | |||||
| 14-Day RSI | 48.48 | |||||
| 6-1 Month Momentum % | -22.22 | |||||
| 12-1 Month Momentum % | -25.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.18 | |||||
| Quick Ratio | 1.14 | |||||
| Cash Ratio | 0.25 | |||||
| Days Inventory | 7.5 | |||||
| Days Sales Outstanding | 62.26 | |||||
| Days Payable | 106.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.1 | |||||
| Dividend Payout Ratio | 0.14 | |||||
| Forward Dividend Yield % | 2.1 | |||||
| 5-Year Yield-on-Cost % | 2.13 | |||||
| 3-Year Average Share Buyback Ratio | -6.3 | |||||
| Shareholder Yield % | -22.91 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 11.56 | |||||
| Operating Margin % | 4.61 | |||||
| Net Margin % | 1.57 | |||||
| FCF Margin % | -12.66 | |||||
| ROE % | 7.43 | |||||
| ROA % | 2.61 | |||||
| ROIC % | 6.8 | |||||
| ROC (Joel Greenblatt) % | 31.09 | |||||
| ROCE % | 20.52 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.44 | |||||
| PE Ratio without NRI | 6.64 | |||||
| Shiller PE Ratio | 21.02 | |||||
| Price-to-Owner-Earnings | 1.24 | |||||
| PS Ratio | 0.12 | |||||
| PB Ratio | 0.55 | |||||
| Price-to-Tangible-Book | 0.64 | |||||
| EV-to-EBIT | 2.96 | |||||
| EV-to-EBITDA | 2.6 | |||||
| EV-to-Revenue | 0.13 | |||||
| EV-to-FCF | -1.06 | |||||
| Price-to-Projected-FCF | 0.2 | |||||
| Price-to-Graham-Number | 0.43 | |||||
| Price-to-Net-Current-Asset-Value | 2.07 | |||||
| Earnings Yield (Greenblatt) % | 33.78 | |||||
| FCF Yield % | -108.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinco Pharmaceutical Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 3,229.631 | ||
| EPS (TTM) (HK$) | 0.025 | ||
| Beta | 0.59 | ||
| Volatility % | 30.78 | ||
| 14-Day RSI | 48.48 | ||
| 14-Day ATR (HK$) | 0.008719 | ||
| 20-Day SMA (HK$) | 0.1859 | ||
| 12-1 Month Momentum % | -25.41 | ||
| 52-Week Range (HK$) | 0.162 - 0.32 | ||
| Shares Outstanding (Mil) | 2,032.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinco Pharmaceutical Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinco Pharmaceutical Holdings Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinco Pharmaceutical Holdings Ltd Frequently Asked Questions
What is Sinco Pharmaceutical Holdings Ltd(HKSE:06833)'s stock price today?
The current price of HKSE:06833 is HK$0.19. The 52 week high of HKSE:06833 is HK$0.32 and 52 week low is HK$0.16.
When is next earnings date of Sinco Pharmaceutical Holdings Ltd(HKSE:06833)?
The next earnings date of Sinco Pharmaceutical Holdings Ltd(HKSE:06833) is .
Does Sinco Pharmaceutical Holdings Ltd(HKSE:06833) pay dividends? If so, how much?
The Dividend Yield %  of Sinco Pharmaceutical Holdings Ltd(HKSE:06833) is 2.1% (As of Today), Highest Dividend Payout Ratio of Sinco Pharmaceutical Holdings Ltd(HKSE:06833) was 0.42. The lowest was 0.14. And the median was 0.32. The  Forward Dividend Yield % of Sinco Pharmaceutical Holdings Ltd(HKSE:06833) is 2.1%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers